Cargando…

Secondary ganglioside GM2 accumulation in mucopolysaccharidoses

Detalles Bibliográficos
Autor principal:	Sandhoff, Konrad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8403895/ https://www.ncbi.nlm.nih.gov/pubmed/34485082 http://dx.doi.org/10.1016/j.ymgmr.2021.100789

Ejemplares similares

Response to Letter to the Editor: Secondary ganglioside G(M2) accumulation in mucopolysaccharidoses
por: Derrick-Roberts, Ainslie L.K.
Publicado: (2021)

Mechanism of Secondary Ganglioside and Lipid Accumulation in Lysosomal Disease
por: Breiden, Bernadette, et al.
Publicado: (2020)

Biochemical Correction of GM2 Ganglioside Accumulation in AB-Variant GM2 Gangliosidosis
por: Deschenes, Natalie M., et al.
Publicado: (2023)

Pathophysiology of Ganglioside GM1 in Ischemic Stroke: Ganglioside GM1: A Critical Review
por: Zhang, Wenchao, et al.
Publicado: (2019)

Ganglioside GM2: a potential biomarker for cholangiocarcinoma
por: Talabnin, Krajang, et al.
Publicado: (2020)

Physiopathological function of hematoside (GM3 ganglioside)
por: INOKUCHI, Jin-ichi
Publicado: (2011)

Ganglioside GM1 and the Central Nervous System
por: Guo, Zhongwu
Publicado: (2023)

Clinical Heterogeneity of Anti-GM2-Ganglioside-Antibody Syndrome
por: Kim, Jong Kuk, et al.
Publicado: (2018)

Altered Expression of Ganglioside Metabolizing Enzymes Results in GM3 Ganglioside Accumulation in Cerebellar Cells of a Mouse Model of Juvenile Neuronal Ceroid Lipofuscinosis
por: Somogyi, Aleksandra, et al.
Publicado: (2018)

Turning the spotlight on the oligosaccharide chain of GM1 ganglioside
por: Chiricozzi, Elena, et al.
Publicado: (2021)

Ganglioside GM3 Is Antiangiogenic in Malignant Brain Cancer
por: Seyfried, Thomas N., et al.
Publicado: (2010)

GM1 ganglioside-independent intoxication by Cholera toxin
por: Cervin, Jakob, et al.
Publicado: (2018)

The Key Role of GM1 Ganglioside in Parkinson’s Disease
por: Chowdhury, Suman, et al.
Publicado: (2022)

Sialidase NEU3 action on GM1 ganglioside is neuroprotective in GM1 gangliosidosis
por: Allende, Maria L., et al.
Publicado: (2023)

Novel Drug Candidates Improve Ganglioside Accumulation and Neural Dysfunction in GM1 Gangliosidosis Models with Autophagy Activation
por: Kajihara, Ryutaro, et al.
Publicado: (2020)

Anti-inflammatory role of GM1 and other gangliosides on microglia
por: Galleguillos, Danny, et al.
Publicado: (2022)

The cytoprotective role of GM1 ganglioside in Huntington disease cells
por: Hart, Hannah S., et al.
Publicado: (2022)

GM2 ganglioside accumulation causes neuroinflammation and behavioral alterations in a mouse model of early onset Tay-Sachs disease
por: Demir, Seçil Akyıldız, et al.
Publicado: (2020)

Mucopolysaccharidoses: Cellular Consequences of Glycosaminoglycans Accumulation and Potential Targets
por: Leal, Andrés Felipe, et al.
Publicado: (2022)

Preparation of Ganglioside GM1 by Supercritical CO(2) Extraction and Immobilized Sialidase
por: Ji, Li, et al.
Publicado: (2019)

GM2-GM3 gangliosides ratio is dependent on GRP94 through down-regulation of GM2-AP cofactor in brain metastasis cells
por: Bedia, Carmen, et al.
Publicado: (2019)

Ganglioside GM1 Targets Astrocytes to Stimulate Cerebral Energy Metabolism
por: Finsterwald, Charles, et al.
Publicado: (2021)

NGcGM3 Ganglioside: A Privileged Target for Cancer Vaccines
por: Fernandez, Luis E., et al.
Publicado: (2010)

GM(1) Ganglioside Inhibits β‐Amyloid Oligomerization Induced by Sphingomyelin
por: Amaro, Mariana, et al.
Publicado: (2016)

Disease‐modifying effects of ganglioside GM1 in Huntington's disease models
por: Alpaugh, Melanie, et al.
Publicado: (2017)

Ganglioside GM3 Synthase Deficiency in Mouse Models and Human Patients
por: Inamori, Kei-ichiro, et al.
Publicado: (2022)

The relationship between depletion of brain GM1 ganglioside and Parkinson's disease
por: Sonnino, Sandro
Publicado: (2023)

Pre-diagnosing and managing patients with GM1 gangliosidosis and related disorders by the evaluation of GM1 ganglioside content
por: Tonin, Rodolfo, et al.
Publicado: (2019)

In situ detection of GM1 and GM2 gangliosides using immunohistochemical and immunofluorescent techniques for auxiliary diagnosis of canine and feline gangliosidoses
por: Kohyama, Moeko, et al.
Publicado: (2016)

Elevated ganglioside GM2 activator (GM2A) in human brain tissue reduces neurite integrity and spontaneous neuronal activity
por: Hsieh, Yi-Chen, et al.
Publicado: (2022)

The biologic role of ganglioside in neuronal differentiation--effects of GM1 ganglioside on human neuroblastoma SH-SY5Y cells.
por: Lee, M. C., et al.
Publicado: (1994)

Disordered testosterone transport in mice lacking the ganglioside GM2/GD2 synthase gene
por: Furukawa, Koichi, et al.
Publicado: (2023)

Sphingomyelinase‐Mediated Multitimescale Clustering of Ganglioside GM1 in Heterogeneous Lipid Membranes
por: Lee, Hyun‐Ro, et al.
Publicado: (2021)

Ganglioside GM3 Has an Essential Role in the Pathogenesis and Progression of Rheumatoid Arthritis
por: Tsukuda, Yukinori, et al.
Publicado: (2012)

Longitudinal Evolution of the Concentration of Gangliosides GM3 and GD3 in Human Milk
por: Giuffrida, Francesca, et al.
Publicado: (2014)

Protection against Experimental Stroke by Ganglioside GM1 Is Associated with the Inhibition of Autophagy
por: Li, Li, et al.
Publicado: (2016)

GM1 Ganglioside Promotes Osteogenic Differentiation of Human Tendon Stem Cells
por: Bergante, Sonia, et al.
Publicado: (2018)

The Role of Lipid Environment in Ganglioside GM1-Induced Amyloid β Aggregation
por: Rudajev, Vladimir, et al.
Publicado: (2020)

Anti-Inflammatory Effects of GM1 Ganglioside on Endotoxin-Induced Uveitis in Rats
por: Weng, Tzu-Heng, et al.
Publicado: (2022)

CREB5 hypermethylation involved in the ganglioside GM1 therapy of Parkinson’s disease
por: Wang, Rui, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ovrdrsrlmof7dk7ga6feivu0mp